Curis Inc (CRIS)

$0.45 0.0025 (0.55%)

16:00 EDT CRIS Stock Quote Delayed 30 Minutes

Why Is Curis (CRIS) Stock Up 20% Today?

By David Moadel, InvestorPlace Contributor Aug 18, 2022

Curis just received a regulatory nod for its lymphoma treatment study from the FDA. Now CRIS stock traders are buying today.

6 Penny Stocks With 1,000% Upside Potential

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

More Articles

Volume:

Previous Close -

Market Cap 41.26M

PE Ratio 0.63

EPS 0.72

Volume (Avg. Vol.) 106,879

Day's Range $0.45 - $0.46

52-Week Range $0.43 - $1.00

Dividend & Yield N/A (N/A)

CRIS Stock Predictions, Articles, and Curis Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer May 13, 2021

We're starting the day off right with a look at the biggest pre-market stock movers for Thursday with earnings backing much of that movement.

CRIS Stock News: Why Biotech Stock Curis Is Going Gangbusters

By William White, InvestorPlace Writer Dec 8, 2020

Curis (CRIS) stock is taking off on Tuesday following news of positive preliminary data from a Phase 1 clinical trial for its leukemia drug.

Biotech News: Why Curis Stock Is Soaring Today

By William White, InvestorPlace Writer Mar 25, 2019

A recent bit of biotech news involving Curis making a deal with Oberland Capital Management has CRIS stock flying high on Monday.

37 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 26, 2016

This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Hottest Manufacturing Stocks Now – GLF ADHD FBIO CRIS

By Portfolio Grader Dec 20, 2016

The following stocks were moving the Manufacturing sector today.

Hottest Manufacturing Stocks Now – AQXP CRIS FTK PPSI

By Portfolio Grader Dec 15, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

21 Biotechnology Stocks to Buy Now

By Portfolio Grader Oct 17, 2016

This week, 21 Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Biggest Movers in Manufacturing Stocks Now – MCUR IPCI TSRO AEHR

By Portfolio Grader Oct 10, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – STML CRBP CRIS OPXA

By Portfolio Grader Oct 7, 2016

The following stocks were moving the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – ABEO CRIS MDGL EDGE

By Portfolio Grader Oct 5, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Hottest Manufacturing Stocks Now – AEGR IDRA LJPC ESPR

By Portfolio Grader Sep 20, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

10 Biotechnology Stocks to Sell Now

By Portfolio Grader Aug 1, 2016

This week, 10 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

27 Biotechnology Stocks to Sell Now

By Portfolio Grader May 16, 2016

The ratings of 27 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Best-of-Breed Small Caps: Biotech Stocks to Buy

By Jason Jenkins, InvestorPlace Contributor Apr 6, 2015

These three small-cap biotech stocks have a bright future and the ability to create advantages in the market.

Curis launches ~$15.1M registered direct offering (NASDAQ:CRIS)

From Seeking Alpha Jul 6, 2023

Biotechnology company Curis (CRIS) said on Thursday that it is launching an ~$15.1M registered direct offering priced at-the-market.

Curis stock falls as FDA lifts partial clinical hold

From Seeking Alpha Jul 6, 2023

Curis (CRIS) said Thursday the FDA removed the partial clinical hold on the company’s Phase 1/2 TakeAim Leukemia trial for lead candidate emavusertib. Read more here.

JonesTrading Sticks to Its Buy Rating for Curis (CRIS)

From TipRanks Dec 12, 2022

JonesTrading analyst Soumit Roy maintained a Buy rating on Curis (CRIS – Research Report) today and set a price target of $5.00. The company’s shar...

Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), Curis (CRIS) and AquaBounty Technologies (AQB)

From TipRanks Nov 10, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Delcath Systems (

Curis (CRIS) Receives a Buy from JonesTrading

From TipRanks Nov 9, 2022

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Curis (CRIS – Research Report), with a price target of $5.00. The company&...

JonesTrading Remains a Buy on Curis (CRIS)

From TipRanks Oct 11, 2022

In a report released yesterday, Soumit Roy from JonesTrading maintained a Buy rating on Curis (CRIS – Research Report), with a price target of $7.00. The comp...